PWPS
RCUS icon

Pinnacle Wealth Planning Services’s Arcus Biosciences RCUS Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.7K Buy
2,714
+48
+2% +$1.19K 0.01% 963
2026
Q1 		$57.6K Buy
2,666
+103
+4% +$2.22K 0.01% 1119
2025
Q4 		$61.1K Buy
+2,563
New +$52.3K 0.01% 1064
2021
Q1 		– Sell
-1,165
Closed -$30K – 1580
2020
Q4 		$30K Buy
+1,165
New +$28.2K 0.01% 1003

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Pinnacle Wealth Planning Services's RCUS Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Arcus Biosciences (RCUS) stake by 1.8% in Q2 2026, buying an estimated $1.19K and bringing the position to 2,714 shares worth $83.7K. The position accounts for 0.01% of the portfolio, ranked #963.

Pinnacle Wealth Planning Services first reported a position in RCUS in Q4 2020 and has held it in 4 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Pinnacle Wealth Planning Services held 2,714 shares of Arcus Biosciences worth $83.7K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 48 Arcus Biosciences shares in Q2 2026, an estimated $1.19K.
  • Arcus Biosciences made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #963 holding.
  • Pinnacle Wealth Planning Services first reported a position in Arcus Biosciences in Q4 2020 and has held it in 4 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.